Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 7, 2012; 18(9): 944-951
Published online Mar 7, 2012. doi: 10.3748/wjg.v18.i9.944
Table 1 Tokyo guideline diagnostic criteria and severity assessment of acute cholecystitis
Diagnosis criteria
A: Local signs of inflammation
Murphy’s sign
Rright upper quadrant mass/pain/tenderness
B: Systemic signs of inflammation
Fever
Elevated C-reactive protein
Elevated white blood cell count
C: Imaging findings
Sonographic Murphy sign
Thickened gallbladder wall
Enlarged gallbladder
Pericholecystic fluid collection
Sonolucent layer in the gallbladder wall
Definite diagnosis
One item in A and one in B are positive
C confirms the diagnosis when acute cholecystitis is suspected clinically1
Severity assessment
Mild (grade I)
Acute cholecystitis does not meet the criteria of severe (grade III) or moderate (grade II) acute cholecystitis or acute cholecystitis in a healthy patient with no organ dysfunction and mild inflammatory changes in the gallbladder, making cholecystectomy a safe and low risk operative procedure
Moderate (grade II)
Elevated WBC count (> 18 000/mm3)
Palpable tender mass in the right upper quadrant
Duration of complains > 72 h2
Marked local inflammation (biliary peritonitis, pericholecystic abscess, hepatic abscess, gangrenous cholecystitis, emphysematous cholecystitis)
Severe (grade III)
Acute cholecystitis associated with dysfunction of any one of the following organs/systems
Cardiovascular dysfunction (hypotension requiring treatment with dopamine ≥ 5 μg/kg per minute, or any dose of dobutamine)
Neurological dysfunction (decreased level of consciousness)
Respiratory dysfunction (PaO2/FiO2 ratio < 300)
Renal dysfunction (oliguria, creatinine > 2.0 mg/dL)
Hepatic dysfunction (PT-INR > 1.5)